MENU
+Compare
ADPT
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$9.87
Change
-$0.11 (-1.10%)
Capitalization
1.5B

ADPT Adaptive Biotechnologies Corp Forecast, Technical & Fundamental Analysis

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease... Show more

ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADPT with price predictions
Jun 04, 2025

Momentum Indicator for ADPT turns positive, indicating new upward trend

ADPT saw its Momentum Indicator move above the 0 level on May 29, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ADPT just turned positive on June 03, 2025. Looking at past instances where ADPT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

ADPT moved above its 50-day moving average on May 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ADPT crossed bullishly above the 50-day moving average on May 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 137 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ADPT moved out of overbought territory on May 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADPT broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.874) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). ADPT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (7.704) is also within normal values, averaging (265.014).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADPT is expected to report earnings to rise 20.00% to -23 cents per share on July 30

Adaptive Biotechnologies Corp ADPT Stock Earnings Reports
Q2'25
Est.
$-0.24
Q1'25
Beat
by $0.09
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.02
The last earnings report on May 01 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 1.01M shares outstanding, the current market capitalization sits at 1.50B.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of an immune medicine platform

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Hospital Or Nursing Management
Address
1165 Eastlake Avenue East
Phone
+1 206 659-0067
Employees
709
Web
https://www.adaptivebiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNICX30.75N/A
N/A
Fidelity Advisor New Insights C
LCGFX29.34N/A
N/A
William Blair Large Cap Growth I
PJDCX17.43N/A
N/A
PGIM Jennison Rising Dividend C
MCIMX21.89N/A
N/A
Victory Integrity Mid-Cap Value C
RYTFX7.41-0.04
-0.54%
Royce Small-Cap Total Return Svc

ADPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+0.40%
AXON - ADPT
56%
Loosely correlated
+2.76%
VCYT - ADPT
54%
Loosely correlated
+2.98%
ARRY - ADPT
50%
Loosely correlated
-0.43%
BEAM - ADPT
50%
Loosely correlated
+1.60%
TECH - ADPT
49%
Loosely correlated
+2.19%
More